← All Topics / ade

FDA ADE reports for Lokivetmab

ade_lokivetmab_adverse_events

ade en 2026-07-22

Lokivetmab — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Lokivetmab is a active ingredient.

Total reports

Lokivetmab: 199

Reports by species (top entries)

  • Dog 199

Top reported reactions (VEDDRA terms, top entries)

  • Lack of efficacy - NOS 29
  • Vomiting 21
  • Lethargy (see also Central nervous system depression in Neurological) 18
  • Decreased appetite 17
  • Diarrhoea 13
  • Elevated serum alkaline phosphatase (SAP) 13
  • Elevated alanine aminotransferase (ALT) 12
  • Lethargy (see also Central nervous system depression in 'Neurological') 11
  • Abnormal adrenocorticotropic hormone (ACTH) stimulation test 10
  • Ear discharge 10

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Lokivetmab (active ingredient) — total reports, species & reaction breakdown
Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports
US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b18.json

Link points to the issuing authority's site; a direct document link is still being verified.